Altered cytoskeleton organization in platelets from patients with MYH9-related disease

I Canobbio1, P Noris, A Pecci

  • 1Centre of Excellence for Applied Biology, Department of Biochemistry, University of Pavia, Pavia, Italy.

Insights

Mutations in the MYH9 gene cause MYH9-related disease (MYH9-RD), leading to altered platelet cytoskeleton composition and reorganization. These changes explain functional deficits and abnormal platelet formation in patients.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • MYH9-related disease (MYH9-RD) is an autosomal dominant disorder caused by mutations in the MYH9 gene.
  • It is characterized by thrombocytopenia and giant platelets, with MYH9 encoding non-muscle myosin IIA, the only myosin isoform in platelets.
  • The impact of MYH9 mutations on platelet contractile structure organization remained uninvestigated.

Purpose of the Study:

  • To investigate the composition and agonist-induced reorganization of the platelet cytoskeleton in MYH9-RD patients.
  • To determine if MYH9 mutations affect cytoskeletal organization and protein interactions within platelets.

Main Methods:

  • Analysis of platelet cytoskeleton composition from seven MYH9-RD patients across four families.
  • Assessment of cytoskeletal protein changes and interactions upon platelet stimulation with agonists.

Main Results:

  • Resting MYH9-RD platelets showed increased constitutive association of myosin with actin in the cytoskeleton.
  • Platelet stimulation resulted in an impaired increase in total cytoskeletal proteins.
  • Key proteins, including glycoproteins, tyrosine kinases, and small GTPases, failed to interact with the cytoskeleton upon stimulation.

Conclusions:

  • MYH9 mutations alter platelet cytoskeleton composition and agonist-induced reorganization.
  • These cytoskeletal abnormalities provide a biochemical basis for functional deficits in MYH9-RD platelets.
  • The findings may explain abnormal platelet formation from megakaryocytes, leading to thrombocytopenia and giant platelets.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...